
3M Posts 4.3% Sales Growth to $6.5B Amid PFAS Litigation Pressures
3M CompanyDescription
What this story covers
3M's Q3 2025 10-Q shows 4.3% sales rise to $6.5B, driven by organic growth in safety and electronics, but net income fell to $834M due to Solventum charges and costs. Balance sheet solid with $4.7B cash despite $1.8B PFAS payments; strategy focuses on divestitures and PFAS exit for efficiency. Risks from litigation loom large, with $7.5B accrued.
Story snapshot
Company3M Company
TickerMMM
VariantStandard detailed
Duration12:34
Filing type10-Q
PeriodQ3 2025
IndustryIndustrials & Manufacturing
Accession0000066740-25-000089
Full Story Script
Content not available for this story.